£319.97

Cellular and Molecular Mechanisms in Alzheimer’s Disease Therapeutics: 2-volume set

Price data last checked 18 day(s) ago - will refresh soon

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£320 today · cheaper than every other day in the last 1 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 14 days · 14 data points (no recent data)

Historical
Generating forecast…
£319.97 £303.97 £310.37 £316.77 £323.17 £329.57 £335.97 05 August 2026 08 August 2026 11 August 2026 14 August 2026 18 August 2026

Price Distribution

Price distribution over 14 days • 1 price levels

Days at Price
14 days 0 4 7 11 14 £320 Days at Price

Price Analysis

Most common price: £320 (14 days, 100.0%)

Price range: £320 - £320

Price levels: 1 different prices over 14 days

Description

Alzheimer’s disease (AD) stands as a profound and growing global health concern, characterized by progressive neurodegeneration and cognitive decline. As research into the underlying causes of AD advances, it becomes clear that a deeper understanding of its molecular mechanisms is crucial for the development of effective therapeutic interventions. This new two-volume set, Cellular and Molecular Mechanism in Alzheimer’s Disease Therapeutics, presents a detailed exploration of the cellular and molecular processes that drive the onset and progression of Alzheimer’s disease. The volume brings together leading experts who offer insights into the intricate cellular and molecular pathways involved in AD pathology as well as potential therapeutic targets and innovative treatment strategies. Volume 1: Cellular Mechanism in Alzheimer’s Disease Therapeutics presents a detailed and up-to-date exploration of the cellular processes involved in AD, with an emphasis on their implications for therapeutic interventions. The book offers a comprehensive understanding of how various cellular mechanisms, such as synaptic dysfunction, neuroinflammation, mitochondrial impairment, and protein aggregation, contribute to the pathology of disease. Topics include blood-brain barrier dysfunction in AD, personalized medicine approaches based on genetic profiling, microRNAs in the management of disease, and more. Volume 2: Molecular Mechanism in Alzheimer’s Disease Therapeutics provides a comprehensive understanding of the disease at a molecular level, from the misfolding and aggregation of amyloid-beta and tau proteins to the disruptions in cellular homeostasis, mitochondrial dysfunction, and neuroinflammation. The volume presents some emerging tools and novel therapeutics and also discusses pharmacological modulation of neurodegenerative disorders, behavioral intervention and cognitive training in AD management, customizing therapies to individual genetic and molecular characteristics, ethical considerations in clinical trials and research, international efforts in AD research and treatment, and more. This volume bridges the gap between molecular research and therapeutic applications, shedding light on the latest findings related to disease mechanisms, such as oxidative stress, synaptic alterations, and the role of neuroinflammatory pathways. Unlike other texts, these two volumes integrate the latest research on biomarkers, drug development, and innovative treatment strategies, offering a comprehensive and up-to-date resource. The unique focus on both fundamental science and practical therapeutic applications makes this two-volume set an invaluable guide for researchers, clinicians, and students aiming to advance their understanding and treatment of disease. By focusing on the cellular and molecular insights into this disease, these volumes pave the way for inspiring novel therapeutic approaches that address the root causes of neurodegeneration.

Product Specifications

Format
hardcover
Domain
Amazon UK
Release Date
18 August 2026
Listed Since
23 April 2026

Barcode

No barcode data available

Similar Products You Might Like

Alzheimer's Disease: Advances in Genetics, Molecular and Cellular Biology
85% match

Alzheimer's Disease: Advances in Genetics, Molecular and Cellular Biology

Springer

£108.01 06 Aug 2026
Chemical Modulators of Protein Misfolding and Neurodegenerative Disease
84% match

Chemical Modulators of Protein Misfolding and Neurodegenerative Disease

Elsevier

£60.49 29 Aug 2026
Advances in Plasma Physics Research: v. 2: Vol 2: Volume 2
84% match

Advances in Plasma Physics Research: v. 2: Vol 2: Volume 2

£61.66 14 Jul 2026
84% match

Building Blocks of Neuroimmunometabolism: From Molecular Pathways to Therapeutic Strategies

Academic Press

£157.99 04 Aug 2026
84% match

Epigenetics and miRNA in Neurodegenerative Diseases: From Molecular Mechanisms to Clinical Applications

Elsevier

£157.99 04 Aug 2026
Research Progress in Alzheimer's Disease and Dementia: v. 3 (Nova Biomedical): Volume 3
83% match

Research Progress in Alzheimer's Disease and Dementia: v. 3 (Nova Biomedical): Volume 3

£59.11 06 Aug 2026
Molecular and Cellular Mechanisms of Neuronal Plasticity: Basic and Clinical Implications: 446 (Advances in Experimental Medicine and Biology, 446)
83% match

Molecular and Cellular Mechanisms of Neuronal Plasticity: Basic and Clinical Implications: 446 (Advances in Experimental Medicine and Biology, 446)

Springer

£108.01 06 Aug 2026
Connections, Cognition and Alzheimer’s Disease (Research and Perspectives in Alzheimer's Disease)
83% match

Connections, Cognition and Alzheimer’s Disease (Research and Perspectives in Alzheimer's Disease)

Springer

£76.42 04 Aug 2026
Molecular and Cellular Mechanisms of Neuronal Plasticity: Basic and Clinical Implications: 446 (Advances in Experimental Medicine and Biology, 446)
82% match

Molecular and Cellular Mechanisms of Neuronal Plasticity: Basic and Clinical Implications: 446 (Advances in Experimental Medicine and Biology, 446)

Springer

£127.87 20 Aug 2026
Alzheimer’s Disease: A Physician’s Guide to Practical Management (Current Clinical Neurology)
82% match

Alzheimer’s Disease: A Physician’s Guide to Practical Management (Current Clinical Neurology)

Humana

£74.21 06 Aug 2026
Neurodegenerative Diseases: Pathology, Mechanisms, and Potential Therapeutic Targets: 15 (Advances in Neurobiology, 15)
82% match

Neurodegenerative Diseases: Pathology, Mechanisms, and Potential Therapeutic Targets: 15 (Advances in Neurobiology, 15)

Springer

£197.47 16 Aug 2026
Neurodegenerative Diseases: Clinical Aspects, Molecular Genetics and Biomarkers
82% match

Neurodegenerative Diseases: Clinical Aspects, Molecular Genetics and Biomarkers

Springer

£117.61 31 Jul 2026
Biomarkers for Alzheimer’s Disease Drug Development: 1750 (Methods in Molecular Biology, 1750)
82% match

Biomarkers for Alzheimer’s Disease Drug Development: 1750 (Methods in Molecular Biology, 1750)

Humana

£58.50 05 Aug 2026
Neurodegenerative Disorders: Loss of Function Through Gain of Function (Research and Perspectives in Alzheimer's Disease)
82% match

Neurodegenerative Disorders: Loss of Function Through Gain of Function (Research and Perspectives in Alzheimer's Disease)

Springer

£108.01 13 Aug 2026
Neurodegenerative Diseases: Integrative PPPM Approach as the Medicine of the Future: 2 (Advances in Predictive, Preventive and Personalised Medicine, 2)
82% match

Neurodegenerative Diseases: Integrative PPPM Approach as the Medicine of the Future: 2 (Advances in Predictive, Preventive and Personalised Medicine, 2)

Springer

£107.23 18 Aug 2026
Neurodegenerative Diseases: Integrative PPPM Approach as the Medicine of the Future: 2 (Advances in Predictive, Preventive and Personalised Medicine, 2)
81% match

Neurodegenerative Diseases: Integrative PPPM Approach as the Medicine of the Future: 2 (Advances in Predictive, Preventive and Personalised Medicine, 2)

Springer

£114.71 05 Aug 2026
Alzheimer's Disease: Methods and Protocols: 32 (Methods in Molecular Medicine, 32)
81% match

Alzheimer's Disease: Methods and Protocols: 32 (Methods in Molecular Medicine, 32)

Humana

£103.27 05 Aug 2026
Current Hypotheses and Research Milestones in Alzheimer's Disease
81% match

Current Hypotheses and Research Milestones in Alzheimer's Disease

Springer

£108.01 05 Aug 2026
Molecular Targets and Therapeutic Design: Volume 153 (Advances in Protein Chemistry and Structural Biology, Volume 153)
81% match

Molecular Targets and Therapeutic Design: Volume 153 (Advances in Protein Chemistry and Structural Biology, Volume 153)

Elsevier

£119.00 06 Aug 2026
81% match

Microglial Advances in Neurodegenerative Diseases (Volume 171) (Advances in Immunology, Volume 171)

Elsevier

£135.00 04 Aug 2026
Pathogenesis of Neurodegenerative Disorders (Contemporary Neuroscience)
81% match

Pathogenesis of Neurodegenerative Disorders (Contemporary Neuroscience)

Humana

£147.14 05 Aug 2026
Macro Roles for MicroRNAs in the Life and Death of Neurons (Research and Perspectives in Neurosciences)
81% match

Macro Roles for MicroRNAs in the Life and Death of Neurons (Research and Perspectives in Neurosciences)

Springer

£75.93 30 Jul 2026
Cellular Mechanisms in Alzheimer’s Disease: 2 (Recent Advances in Alzheimer Research)
81% match

Cellular Mechanisms in Alzheimer’s Disease: 2 (Recent Advances in Alzheimer Research)

Bentham Science Publishers

£97.85 09 Aug 2026
Abeta Peptide and Alzheimer's Disease: Celebrating a Century of Research
81% match

Abeta Peptide and Alzheimer's Disease: Celebrating a Century of Research

Springer

£76.41 06 Aug 2026